Home
Bookstore
DSM IV Diagnosis
BPD Expert Archives
Articles
Research
Chat Transcripts
Consumer's Literary Library
BPD Today Community
Author Interviews
Clinicians That Treat BPD
Resources
Family Index
BPD Survey
Clinician Area
BPD From NIMH
Psychotropic
Medications
Free
Medications
Find
a Therapist
Volunteers
Spiritual
Support
MH Exercises
Award
Sign Up
Disclaimer
Mission
Statement
Privacy
Copyright
BPD
Links
About
Contact
|
BPD Today Newsletters
|
|
Join the BPD
Today Newsletter! Or send a blank email here.
Packed with emotional support, new information, research and site additions.
|
|
|
|
|
Borderline Personality Disorder Research
Borderline Personality Disorder Brain & Medical Issues
Amygdala Hyper-Reactivity in Borderline Personality Disorder: Implications
for Emotional Dysregulation
Biological Psychiatry
Prepublication Article Abstract
Nelson Donegan <mailto:nelson.donegan@yale.edu>, Charles A. Sanislow, Hilary
P. Blumberg, Robert K. Fulbright, Cheryl Lacadie, Pawel Skudlarski, John C.
Gore, Ingrid R. Olson, Thomas H. McGlashan and Bruce E. Wexler
Accepted 6/6/2003
"Background: Disturbed interpersonal relations and emotional dysregulation
are fundamental aspects of Borderline Personality Disorder (BPD). The
amygdala plays important roles in modulating vigilance and generating
negative emotional states and is often abnormally reactive in disorders of
mood and emotion. The objective of this study was to assess amygdala
reactivity in BPD patients relative to normal controls. We hypothesize that
amygdala hyper-reactivity contributes to hypervigilance, emotional
dysregulation, and disturbed interpersonal relations in BPD.
Methods: Using functional magnetic resonance imaging, we examined neural
responses to 20-sec blocks of neutral, happy, sad, and fearful facial
expression (or a fixation point) in 15 BPD and 15 normal control subjects.
The DSM IV-diagnosed BPD patients and the normal control subjects were
assessed by a clinical research team in a medical school psychiatry
department."
September 2003
A voxel-based morphometric MRK study in
female patients with borderline personality disorder
Neuroimage. 2003 Sep;20(1):385-92
Rusch N, Elst LT, Ludaescher P, Wilke M, Huppertz HJ, Thiel T,
Schmahl C, Bohus M, Lieb K, Hesslinger B, Hennig J, Ebert D.
Department of Psychiatry and Psychotherapy, University of
Freiburg, Freiburg, Germany
"Subtle prefrontal and limbic structural abnormalities have been
reported in borderline personality disorder (BPD). In order to
further validate the previously reported findings and to more
precisely describe the nature of the structural change we performed
a voxel-based morphometric (VBM) study in patients with BPD...Gray
matter volume loss was found in the left amygdala. No other
differences in gray or white matter volume or density were found
anywhere else in the brain. Our findings support the hypothesis
that temporolimbic abnormalities play a role in the pathophysiology
of BPD. Prefrontal structural alterations in BPD were not observed
in this study."
July 2003
Neural correlates of memories of abandonment in women with and without borderline personality
disorder
Biol Psychiatry. 2003 Jul 15;54(2):142-51.
Related Articles, Schmahl CG, Elzinga BM, Vermetten E, Sanislow C, McGlashan TH, Bremner JD.
Department of Psychiatry and Psychotherapy, University of Freiburg Medical
School, Freiburg, Germany.
BACKGROUND: Borderline personality disorder (BPD) is a common psychiatric disorder that is often linked to early stressors. One particularly salient feature of the disorder is fear of abandonment. This pilot study was conducted to measure neural correlates of memories of abandonment in women with and without BPD.
METHODS: Twenty women with a history of childhood sexual abuse underwent measurement of brain blood flow with positron emission tomography imaging while they listened to scripts describing neutral and personal abandonment events. Brain blood flow during exposure
to abandonment and neutral scripts was compared among women with and without BPD. RESULTS: Memories of abandonment were associated with greater increases in blood flow in bilateral dorsolateral prefrontal cortex (middle frontal gyrus, Brodmann's areas 9 and 10) as well as right cuneus (area 19) in women with BPD than in women without BPD. Abandonment memories were associated with greater decreases in right anterior cingulate (areas 24 and 32) in women with BPD than in women without BPD.
CONCLUSIONS: These findings implicate dysfunction of dorsolateral and medial prefrontal cortex including anterior cingulate, left temporal
cortex, and visual association cortex in memories of abandonment in women with BPD. These brain areas may mediate symptoms of BPD.
July 2003
Impulsivity and prefrontal hypometabolism in borderline personality disorder.
Psychiatry Res. 2003 Jul 30;123(3):153-63.
Soloff PH, Meltzer CC, Becker C, Greer PJ, Kelly TM, Constantine D.
Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA. soloffph@msx.upmc.edu
"Prefrontal hypoperfusion and decreased glucose uptake in the prefrontal cortex (PFC) are found in violent criminal offenders, murderers and aggressive psychiatric patients. These abnormalities may be independent of diagnosis and associated with impulsive-aggression as a personality trait. Impulsive-aggression is a clinical characteristic of borderline personality disorder (BPD) where it is associated with assaultive and suicidal behaviors...There were no significant areas of increased uptake in BPD subjects compared to control subjects. Covarying for measures of impulsivity or impulsive-aggression rendered insignificant the differences between groups. Decreased glucose uptake in medial orbital frontal cortex may be associated with diminished regulation of impulsive behavior in BPD."
July 2003
Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study.
Biol Psychiatry. 2003 Jul 15;54(2):163-71. Related Articles, Links
Tebartz van Elst L, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, Lieb K, Bohus M, Hennig J, Ebert D.
Department of Psychiatry and Psychotherapy, University of Freiburg, Freiburg, Germany.
BACKGROUND: Dual frontolimbic brain pathology has been suggested as a possible correlate of impulsivity and aggressive behavior. One previous study reported volume loss of the hippocampus and the amygdala in patients with borderline personality disorder. We measured limbic and prefrontal brain volumes to test the hypothesis that frontolimbic brain pathology might be associated with borderline personality disorder... RESULTS: We found a significant reduction of hippocampal and amygdala volumes in borderline personality disorder. There was a significant 24% reduction of the left orbitofrontal and a 26% reduction of the right anterior cingulate cortex in borderline personality disorder. Only left orbitofrontal volumes correlated significantly with amygdala volumes. CONCLUSIONS: While volume loss of a single brain structure like the hippocampus is quite an unspecific finding in neuropsychiatry, the patterns of volume loss of the amygdala, hippocampus, and left orbitofrontal and right anterior cingulate cortex might differentiate borderline personality disorder from other neuropsychiatric conditions.
April 2003
Magnetic resonance imaging of hippocampal and amygdala volume
in women with childhood abuse and borderline personality
disorder.
Psychiatry Res. 2003 Apr 1;122(3):193-8.
Schmahl CG, Vermetten E, Elzinga BM, Douglas Bremner J.
Department of Psychiatry and Psychotherapy, University of Freiburg Medical School, Hauptstrasse 5, D-79104 Freiburg, Germany.
christian_schmahl@psyallg.ukl.uni-freiburg.de
Borderline personality disorder has "been hypothesized to be related to dysfunction of limbic brain areas including hippocampus and amygdala. The purpose of this study was to measure hippocampal and amygdala volumes in BPD. Hippocampal and amygdala volumes were measured with magnetic resonance imaging (MRI) in 10 patients with BPD and 23 control subjects. Patients with BPD had a 21.9% smaller mean amygdala volume and a 13.1% smaller hippocampal volume, compared to controls. These findings are consistent with the hypothesis that alterations in the hippocampus and amygdala are associated with BPD."
March - April 2003
Positron emission tomography in female patients with
Borderline personality disorder.
J Psychiatr Res. 2003 Mar-Apr;37(2):109-15.
Juengling FD, Schmahl C, Hesslinger B, Ebert D, Bremner JD, Gostomzyk J, Bohus M, Lieb K.
Department of Nuclear Medicine, PET group, University of Freiburg Medical School, Hugstetterstr. 55, D-79106, Freiburg, Germany.
Frontal brain imaging study done on 12 females with BPD with no
depression and on no medications against 12 healthy females. Those
with BPD had "significant frontal and prefrontal hypermetabolism"
and significant hypometabolism in the hippocampus and cuneus. This
study shows "limbic and prefrontal dysfunction" in people with
BPD...Dysfunction in this network of brain regions, which has been
implicated in the regulation of emotion, may underlie symptoms of
BPD."
2002
Serum cholesterol and leptin levels in patients with borderline personality disorder.
Neuropsychobiology. 2002;45(4):167-71.
Atmaca M, Kuloglu M, Tezcan E, Gecici O, Ustundag B.
Department of Psychiatry, Firat University, School of Medicine, Elazig, Turkey. matmaca_p@yahoo.com
"...patients with borderline personality disorder have lower cholesterol and leptin levels than healthy controls. Low serum cholesterol and leptin levels are associated with all dimensions of the disorder - impulsivity, aggression and suicidality - but are not associated with the presence and the severity of comorbid depression."
November - December 2000
Biological markers in schizotypal and borderline personality
disorders
Encephale 2000 Nov-Dec;26(6):42-54 (Article in
French)
Ajamieh A, Ansseau M.
Service de Psychiatrie et de Psychologie Medicale, CHU du Sart Tilman, B-4000 Liege, Belgique.
"A preliminary but growing body of evidence supports the existence
of biological substrates in personality disorders. Based on a
review of the literature, the article deals with the major
biological markers: genetic, cognitive, biochemical,
electrophysiological and organic markers, of schizotypal and
borderline personality disorders. In addition, the article compares
these findings in these two types of pathological personality. In
the field of genetics, we notice several indices in favour of a
relationship between schizotypal personality disorder (SPD) and
chronic schizophrenia. In contrast, in borderline personality
disorder (BPD), indices were lacking for such a relationship
between this disorder and one of the axis I diagnosis, or a clear
genetic transmission. In the field of cognitive tests, we can note
in both SPD and BPD, that the abnormalities which would be at the
level of temporal and frontal lobes, may be implicated in the
observable cognitive troubles in these two disorders. In the field
of neurobiochemistry, the dopaminergic and serotonergic systems
seem to be implicated in the etiology of SPD while several data
point out the fact that several neurotransmitter systems
(dopaminergic, serotonergic, noradrenergic and cholinergic) seem to
be involved in the etiology of BPD. Finally, in the field of
electrophysiology, we notice that some of these tests observed in
SPD (smooth pursuit eye movements, evoked potentials, modification
of the electrodermic response) seem reinforcing the relationship
between SPD and schizophrenia while those observed in BPD seem
reinforcing either a relationship between BPD and depression (sleep
studies), or a relationship between BPD and schizophrenia (evoked
potentials, smooth pursuit eye movements)."
February 1998
Electroencephalographic
abnormalities in borderline personality disorder
Psychiatry Res 1998 Feb 9;77(2):131-8
De la Fuente JM, Tugendhaft P, Mavroudakis N.
Psychiatry Department, Erasme Hospital, Free University of
Brussels, Belgium.
"Epilepsy and non-localized brain dysfunction have been invoked,
among others, as underlying factors in borderline personality
disorder. We have recorded 58 electroencephalograms in 20
borderline patients, first after complete drug washout and then
under carbamazepine or placebo double-blind treatment. Taking into
account only definite abnormal tracings, we found a 40% incidence
of abnormal diffuse slow activity. No patient disclosed focal or
epileptiform EEG features. Carbamazepine did not appear to modify
the electroencephalogram."
August 1990
Altered platelet alpha 2-adrenergic receptor binding sites in borderline personality disorder.
Am J Psychiatry. 1990 Aug;147(8):1014-7.
Southwick SM, Yehuda R, Giller EL Jr, Perry BD.
Post Traumatic Stress Disorder Unit, West Haven VA Medical Center, Conn
"The authors found significantly fewer total platelet alpha 2-adrenergic receptor binding sites in 13 nonmedicated patients with borderline personality disorder than in 11 patients with borderline personality disorder who were receiving low doses of benzodiazepines and 18 nonpsychiatric control subjects. The two patient groups showed comparable degrees of depression as assessed by the Hamilton Rating Scale for Depression. However, nonmedicated borderline patients were considerably more anxious than medicated patients, raising the possibility that lower alpha 2-adrenergic receptor binding in borderline personality disorder is related to anxiety."
June 1989
Biologic markers in borderline personality disorder: a
review.
J Clin Psychiatry 1989 Jun;50(6):217-25
Lahmeyer HW, Reynolds CF 3rd, Kupfer DJ, King R.
Department of Psychiatry, University of Illinois, Chicago
60680.
The use of biologic markers in the evaluation of borderline
personality disorder (BPD) patients is reviewed. Many patients with
Axis II BPD have coexisting Axis I diagnoses of which depression is
the most commonly reported. Biologic markers have not aided in the
diagnosis of BPD, but some markers, particularly EEG sleep, are not
only abnormal in BPD, but also appear to discriminate Axis I
depression from other Axis I codiagnoses. Monoamine oxidase, in
vitro red blood cell lithium ratio, and P300 auditory evoked
potential when used alone or in a combined diagnostic approach,
show promise in identifying these codiagnoses as well.
Dexamethasone suppression and thyrotropin-releasing hormone tests
appear nonspecific in this population. Pharmacologic trials have
demonstrated that some BPD patients have good therapeutic response
to antipsychotics and tranylcypromine and poor response to
alprazolam.
Endocrine System
July 2003
Antithyroid antibody-linked symptoms in borderline personality disorder.
Endocrine. 2003 Jul;21(2):153-8
Geracioti TD Jr, Kling MA, Post RM, Gold PW.
Clinical Neuroendocrinology, National Institute of Mental Health, Bethesda, MD, USA.
geracioti@med.va.gov
"Circulating thyroid autoantibodies are more prevalent in patients with mood disorders than in the general population, but longitudinal clinical data that establish a relationship between thyroid antibody status and the course of any psychiatric syndrome have been lacking. In addition, scant attention has been paid to thyroid hormones and autoimmunity in borderline personality disorder (BPD). We report a case of a patient with classic BPD whose fluctuating mood and, especially, psychotic symptoms-rated using a double-blind method-were directly linked to antithyroglobulin antibody titers serially determined over an inpatient period of 275 d. Significantly lower psychosis and depression ratings were seen during a 4-wk period of relatively low antithyroid antibody titers, during blinded treatment with carbamazepine, than were observed during two high autoantibody epochs. The significant positive correlations between nurse- and patient-rated depression and thyroid autoantibodies over the entire period of inpatient study were similar to those also observed between urinary free cortisol levels and depression; the positive correlation between antithyroglubulin antibody titers and psychotic symptoms was stronger (r = +0.544; p < 0.002). Although this patient had biochemical indices of primary hypothyroidism, she showed only marginal improvement to triiodothyronine (T3) and no apparent clinical response to sustained levorotatory thyroxine (T4) administration; neither were antithyroid antibody titers significantly associated with changes in T3, free T4, or thyroid-stimulating hormone concentrations. She clinically deteriorated during a 50-d fluoxetine trial. The present data demonstrate a clinically significant, longitudinal correlation between fluctuating antithyroid antibody titers and symptoms of borderline psychopathology in our patient. It will be of interest to determine the prevalence, pathophysiologic mechanisms, and treatment implications of this putative autoimmune- BPD link."
Material in quotes is from PubMed.
This material is for educational purposes.

Visit
MH Matters for information
and articles. Get
help to find
a therapist or list
your practice; and Psych
Forums for message boards on a variety of MH topics.
Sponsors:
Aphrodite's Love Poetry ¦ Make
Money on the Internet
|
|
|